Diabetes 51:3163-3169, 2002
© 2002 by the American Diabetes Association, Inc.
Altered Myocellular and Abdominal Fat Partitioning Predict Disturbance in Insulin Action in HIV Protease Inhibitor-Related Lipodystrophy
Seng Khee Gan1,
Katherine Samaras1,
Campbell H. Thompson2,
Edward W. Kraegen1,
Andrew Carr3,
David A. Cooper3,4, and
Donald J. Chisholm1
1 Metabolism and Diabetes Research Program, Garvan Institute of Medical Research, Sydney, Australia
2 Department of Biochemistry, University of Sydney, Sydney, Australia
3 HIV Medicine Unit and Centre for Immunology, St. Vincents Hospital, Sydney, Australia
4 National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
HIV protease inhibitor-related lipodystrophy is characterized by peripheral fat loss, hyperlipidemia, and insulin resistance. Increased availability of lipid to muscle may be one of the mechanisms that induce insulin resistance. Regional fat, intramyocellular lipid (by 1H-magnetic resonance spectroscopy), serum lipids, and insulin-stimulated glucose disposal (by hyperinsulinemic-euglycemic clamp) were quantified in 10 men who had HIV-1 infection with moderate to severe lipodystrophy and a control group of 10 nonlipodystrophic men who had HIV-1 infection and were naïve to protease inhibitors to examine the effects of lipodystrophy on glucose and lipid metabolism. Lipodystrophic subjects showed lower insulin-stimulated glucose disposal than control subjects (P = 0.001) and had increased serum triglycerides (P = 0.03), less limb fat (P = 0.02), increased visceral fat as a proportion of total abdominal fat (P = 0.003), and increased intramyocellular lipid (1.90 ± 0.15 vs. 1.23 ± 0.16% of water resonance peak area; P = 0.007). In both groups combined, visceral fat related strongly to intramyocellular lipid (r = 0.83, P < 0.0001) and intramyocellular lipid related negatively to insulin-stimulated glucose disposal (r = -0.71, P = 0.0005). Fasting serum cholesterol and triglycerides related positively to intramyocellular lipid and visceral fat in lipodystrophic subjects only. The data indicate that lipodystrophy is associated with increased lipid content in muscle accompanying impaired insulin action. The results do not establish causation but emphasize the interrelationships among visceral fat, myocyte lipid, and insulin action.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Joy and S. K Grinspoon
Adipose compartmentalization and insulin resistance among obese HIV-infected women: the role of intermuscular adipose tissue
Am. J. Clinical Nutrition,
July 1, 2007;
86(1):
5 - 6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B Albu, S. Kenya, Q. He, M. Wainwright, E. S Berk, S. Heshka, D. P Kotler, and E. S Engelson
Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women
Am. J. Clinical Nutrition,
July 1, 2007;
86(1):
100 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fleischman, S. Johnsen, D. M. Systrom, M. Hrovat, C. T. Farrar, W. Frontera, K. Fitch, B. J. Thomas, M. Torriani, H. C. F. Cote, et al.
Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults
Am J Physiol Endocrinol Metab,
June 1, 2007;
292(6):
E1666 - E1673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hadigan, J. Liebau, M. Torriani, R. Andersen, and S. Grinspoon
Improved Triglycerides and Insulin Sensitivity with 3 Months of Acipimox in Human Immunodeficiency Virus-infected Patients with Hypertriglyceridemia
J. Clin. Endocrinol. Metab.,
November 1, 2006;
91(11):
4438 - 4444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Torriani, B. J. Thomas, R. B. Barlow, J. Librizzi, S. Dolan, and S. Grinspoon
Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution
J Appl Physiol,
February 1, 2006;
100(2):
609 - 614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hadigan, D. Kamin, J. Liebau, S. Mazza, S. Barrow, M. Torriani, R. Rubin, S. Weise, A. Fischman, and S. Grinspoon
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
Am J Physiol Endocrinol Metab,
February 1, 2006;
290(2):
E289 - E298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Torriani and S. Grinspoon
Racial differences in fat distribution: the importance of intermuscular fat
Am. J. Clinical Nutrition,
April 1, 2005;
81(4):
731 - 732.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Grinspoon and A. Carr
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
N. Engl. J. Med.,
January 6, 2005;
352(1):
48 - 62.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B Haugaard, O. Andersen, F. Dela, J. J. Holst, H. Storgaard, M. Fenger, J. Iversen, and S. Madsbad
Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic {beta}-cells
Eur. J. Endocrinol.,
January 1, 2005;
152(1):
103 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Kriketos, J. R. Greenfield, P. W. Peake, S. M. Furler, G. S. Denyer, J. A. Charlesworth, and L. V. Campbell
Inflammation, Insulin Resistance, and Adiposity: A study of first-degree relatives of type 2 diabetic subjects
Diabetes Care,
August 1, 2004;
27(8):
2033 - 2040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Koutkia, B. Canavan, J. Breu, M. L Johnson, A. Depaoli, and S. K Grinspoon
Relation of leptin pulse dynamics to fat distribution in HIV-infected patients
Am. J. Clinical Nutrition,
June 1, 2004;
79(6):
1103 - 1109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Driscoll, G. E. Meininger, K. Ljungquist, C. Hadigan, M. Torriani, A. Klibanski, W. R. Frontera, and S. Grinspoon
Differential Effects of Metformin and Exercise on Muscle Adiposity and Metabolic Indices in Human Immunodeficiency Virus-Infected Patients
J. Clin. Endocrinol. Metab.,
May 1, 2004;
89(5):
2171 - 2178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Havel
Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism
Diabetes,
February 1, 2004;
53(90001):
S143 - 151.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Perseghin, G. Lattuada, M. Danna, L. P. Sereni, P. Maffi, F. De Cobelli, A. Battezzati, A. Secchi, A. Del Maschio, and L. Luzi
Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes
Am J Physiol Endocrinol Metab,
December 1, 2003;
285(6):
E1174 - E1181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Yarasheski, P. Tebas, S. Claxton, D. Marin, T. Coleman, W. G. Powderly, and C. F. Semenkovich
Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia
Am J Physiol Endocrinol Metab,
October 1, 2003;
285(4):
E899 - E905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Torriani, C. Hadigan, M. E. Jensen, and S. Grinspoon
Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome
J Appl Physiol,
September 1, 2003;
95(3):
1005 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|